These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6172022)

  • 1. Serotonin metabolite concentrations in cerebrospinal fluid from schizophrenic patients -- relationships to family history.
    Sedvall G
    Adv Exp Med Biol; 1981; 133():719-25. PubMed ID: 6172022
    [No Abstract]   [Full Text] [Related]  

  • 2. Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Hamato H
    Neurosci Lett; 1993 Feb; 150(1):71-4. PubMed ID: 7682308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan and serotonin metabolism in familial erythrophagocytic lymphohistiocytosis.
    Howells DW; Hyland K; Smith I; Strobel S
    J Inherit Metab Dis; 1992; 15(6):891-7. PubMed ID: 1284084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin, suicide and schizophrenia.
    Roy A
    Can J Psychiatry; 1993 Jun; 38(5):369. PubMed ID: 7688651
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous determination of tryptophan and its 5-hydroxy metabolites in human cerebrospinal fluid by reversed phase liquid chromatography with electrochemical detection.
    Laakso JT; Koskiniemi ML; Wahlroos O; Härkönen M
    Scand J Clin Lab Invest; 1983 Oct; 43(6):463-72. PubMed ID: 6197747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.
    Peters JG
    Eur Neurol; 1979; 18(1):15-8. PubMed ID: 436860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measuring monoamine metabolites and tryptophan levels in the cerebrospinal fluid of alcohol-dependent patients].
    Bánki MC
    Orv Hetil; 1981 Oct; 122(40):2463-9. PubMed ID: 6172767
    [No Abstract]   [Full Text] [Related]  

  • 8. On the concentration of 5-hydroxyindoleacetic acid in schizophrenia: a meta-analysis.
    Tuckwell HC; Koziol JA
    Psychiatry Res; 1996 Jan; 59(3):239-44. PubMed ID: 8930029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia.
    Cooper SJ; Kelly CB; King DJ
    Lancet; 1992 Oct; 340(8825):940-1. PubMed ID: 1383659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of 5-hydroxytryptamine (5-HT) level in cerebrospinal fluid of patients with intracranial or spinal lesions.
    Misra SS; Singh KS; Bhargava KP
    J Neurol Neurosurg Psychiatry; 1967 Apr; 30(2):163-5. PubMed ID: 6034108
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on CSF tryptophan metabolism in infantile spasms.
    Yamamoto H
    Pediatr Neurol; 1991; 7(6):411-4. PubMed ID: 1724601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoamine metabolite levels in cerebrospinal fluid of schizophrenic patients].
    Imazu Y; Kobayashi K; Kawabata M; Shohmori T
    Seishin Shinkeigaku Zasshi; 1985; 87(9):634-42. PubMed ID: 2419935
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for the role of serotonin in the regulation of slow wave sleep in schizophrenia.
    Benson KL; Faull KF; Zarcone VP
    Sleep; 1991 Apr; 14(2):133-9. PubMed ID: 1714097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients.
    Scheepers FE; Gispen-de Wied CC; Westenberg HG; Kahn RS
    Neuropsychopharmacology; 2001 Oct; 25(4):468-75. PubMed ID: 11557160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T; Eriksson M; Sjöberg S; Nordin C
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid.
    Young SN; Anderson GM; Gauthier S; Purdy WC
    J Neurochem; 1980 May; 34(5):1087-92. PubMed ID: 6154772
    [No Abstract]   [Full Text] [Related]  

  • 17. Indoleamine metabolism in rat brain studied through measurements of tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in cerebrospinal fluid.
    Young SN; Anderson GM; Purdy WC
    J Neurochem; 1980 Feb; 34(2):309-15. PubMed ID: 6157779
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid correlates of suicide attempts and aggression.
    Brown GL; Goodwin FK
    Ann N Y Acad Sci; 1986; 487():175-88. PubMed ID: 2436532
    [No Abstract]   [Full Text] [Related]  

  • 19. Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs.
    Young SN; Gauthier S; Anderson GM; Purdy WC
    J Neurol Neurosurg Psychiatry; 1980 May; 43(5):438-45. PubMed ID: 6158559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumvention of defective neutral amino acid transport in Hartnup disease using tryptophan ethyl ester.
    Jonas AJ; Butler IJ
    J Clin Invest; 1989 Jul; 84(1):200-4. PubMed ID: 2472426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.